These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 3541714)
1. The bronchodilator effect of caffeine in adult asthmatics. Bukowskyj M; Nakatsu K Am Rev Respir Dis; 1987 Jan; 135(1):173-5. PubMed ID: 3541714 [TBL] [Abstract][Full Text] [Related]
2. Bronchodilator effects of caffeine in coffee. A dose-response study of asthmatic subjects. Gong H; Simmons MS; Tashkin DP; Hui KK; Lee EY Chest; 1986 Mar; 89(3):335-42. PubMed ID: 3948545 [TBL] [Abstract][Full Text] [Related]
3. The bronchodilator effects and pharmacokinetics of caffeine in asthma. Becker AB; Simons KJ; Gillespie CA; Simons FE N Engl J Med; 1984 Mar; 310(12):743-6. PubMed ID: 6700656 [TBL] [Abstract][Full Text] [Related]
4. Forced expiratory decay in asthmatic preschool children--is it adult type? Vilozni D; Hakim F; Livnat G; Bentur L Respir Med; 2013 Jul; 107(7):975-80. PubMed ID: 23664671 [TBL] [Abstract][Full Text] [Related]
5. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group. Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir. Cass LM; Gunawardena KA; Macmahon MM; Bye A Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma. Rabe KF; Jörres R; Nowak D; Behr N; Magnussen H Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1436-41. PubMed ID: 8503554 [TBL] [Abstract][Full Text] [Related]
8. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease. Chhabra SK; Bhatnagar S Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258 [TBL] [Abstract][Full Text] [Related]
9. The effect of tiotropium on the pulmonary diffusing capacity. Gonlugur U Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):535-7. PubMed ID: 18040529 [TBL] [Abstract][Full Text] [Related]
10. The clinical significance of volume-adjusted maximal mid-expiratory flow (Iso-volume FEF25-75%) in assessing airway responsiveness to inhaled bronchodilator in asthmatics. Boggs PB; Bhat KD; Vekovius WA; Debo MS Ann Allergy; 1982 Mar; 48(3):139-42. PubMed ID: 7065476 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of lung function and deposition of aerosolized bronchodilators carried by heliox associated with positive expiratory pressure in stable asthmatics: a randomized clinical trial. Alcoforado L; Brandão S; Rattes C; Brandão D; Lima V; Ferreira Lima G; Fink JB; Dornelas de Andrade A Respir Med; 2013 Aug; 107(8):1178-85. PubMed ID: 23664767 [TBL] [Abstract][Full Text] [Related]
12. The effect of bucindolol on the airway function of asthmatics. Ruffin RE; Crockett AJ; Alpers JH Eur J Clin Pharmacol; 1986; 30(5):559-65. PubMed ID: 3530781 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma. Bjermer L; Rosenborg J; Bengtsson T; Lötvall J Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810 [TBL] [Abstract][Full Text] [Related]
14. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Tan S; Hall IP; Dewar J; Dow E; Lipworth B Lancet; 1997 Oct; 350(9083):995-9. PubMed ID: 9329515 [TBL] [Abstract][Full Text] [Related]
15. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide. de Jong JW; van der Mark TW; Koëter GH; Postma DS Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165 [TBL] [Abstract][Full Text] [Related]
16. Bronchodilator effect of sublingual isosorbide dinitrate in asthma. Okayama M; Sasaki H; Takishima T Eur J Clin Pharmacol; 1984; 26(2):151-5. PubMed ID: 6373302 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials. Franciosi LG; Diamant Z; Banner KH; Zuiker R; Morelli N; Kamerling IM; de Kam ML; Burggraaf J; Cohen AF; Cazzola M; Calzetta L; Singh D; Spina D; Walker MJ; Page CP Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275 [TBL] [Abstract][Full Text] [Related]
18. A comparison of inhaled fenoterol and albuterol in asthma. König P; Hordvik NL; Sunderrajan EV Ann Allergy; 1985 Nov; 55(5):691-3. PubMed ID: 4061978 [TBL] [Abstract][Full Text] [Related]
19. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study. Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051 [TBL] [Abstract][Full Text] [Related]
20. The development of subsensitivity to atropine methylnitrate. A double-blind, placebo-controlled crossover study. Vaughan TR; Bowen RE; Goodman DL; Weber RW; Nelson HS Am Rev Respir Dis; 1988 Oct; 138(4):771-4. PubMed ID: 3059882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]